1. Home
  2. ORIC vs MFA Comparison

ORIC vs MFA Comparison

Compare ORIC & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • MFA
  • Stock Information
  • Founded
  • ORIC 2014
  • MFA 1997
  • Country
  • ORIC United States
  • MFA United States
  • Employees
  • ORIC N/A
  • MFA N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • MFA Real Estate Investment Trusts
  • Sector
  • ORIC Health Care
  • MFA Real Estate
  • Exchange
  • ORIC Nasdaq
  • MFA Nasdaq
  • Market Cap
  • ORIC 1.1B
  • MFA 930.2M
  • IPO Year
  • ORIC 2020
  • MFA N/A
  • Fundamental
  • Price
  • ORIC $13.16
  • MFA $8.99
  • Analyst Decision
  • ORIC Strong Buy
  • MFA Buy
  • Analyst Count
  • ORIC 8
  • MFA 7
  • Target Price
  • ORIC $16.57
  • MFA $11.00
  • AVG Volume (30 Days)
  • ORIC 1.5M
  • MFA 1.3M
  • Earning Date
  • ORIC 11-06-2025
  • MFA 11-06-2025
  • Dividend Yield
  • ORIC N/A
  • MFA 16.02%
  • EPS Growth
  • ORIC N/A
  • MFA 41.64
  • EPS
  • ORIC N/A
  • MFA 0.88
  • Revenue
  • ORIC N/A
  • MFA $284,489,000.00
  • Revenue This Year
  • ORIC N/A
  • MFA N/A
  • Revenue Next Year
  • ORIC N/A
  • MFA $14.85
  • P/E Ratio
  • ORIC N/A
  • MFA $10.21
  • Revenue Growth
  • ORIC N/A
  • MFA 9.37
  • 52 Week Low
  • ORIC $3.90
  • MFA $7.85
  • 52 Week High
  • ORIC $14.93
  • MFA $12.64
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 54.79
  • MFA 40.61
  • Support Level
  • ORIC $12.75
  • MFA $9.04
  • Resistance Level
  • ORIC $13.80
  • MFA $9.17
  • Average True Range (ATR)
  • ORIC 0.72
  • MFA 0.16
  • MACD
  • ORIC -0.08
  • MFA 0.01
  • Stochastic Oscillator
  • ORIC 58.97
  • MFA 36.54

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.

Share on Social Networks: